🔎 Trials Near Me

Utama › Leukemia Mieloid Kronik › New York

Kajian klinikal Leukemia Mieloid Kronik di New York

15 kajian untuk Leukemia Mieloid Kronik sedang mencari peserta di lokasi di New York.

Bandar di New York

Teks kajian rasmi (Bahasa Inggeris)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Queens Hospital Center, Jamaica
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Stony Brook University Medical Center, Stony Brook
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Study of Olverembatinib (HQP1351) in Patients With CML-CP

  • Ascentage Investigative Site #1068, Rochester
  • Ascentage Investigative Site #1053, Shirley
  • Ascentage Investigative Site #1160, Stony Brook
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06423911

Cord Blood Transplant in Adults With Blood Cancers

  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 2
Umur 21 hingga 65 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT05884333

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

  • Columbia University Medical Center New York Presbyterian, New York
Mengambil pesertaFasa 2
Umur 1 hingga 18 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07354074

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04838041

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • Roswell Park Cancer Institute, Buffalo
  • North Shore University Hospital, Lake Sucess
  • Cohen Children's Medical Center of New York, New Hyde
  • dan 9 lagi
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545

Asciminib Roll-over Study

  • Memorial Sloan Kettering, New York
Mengambil pesertaFasa 4
Umur 7 hingga 100 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT04877522

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

  • University of Rochester NCORP Research Base, Rochester
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT07638007

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

  • Wilmot Cancer Institute, University of Rochester, Rochester
Mengambil pesertaFasa awal 1
Umur 18 hingga 75 · Semua jantina · Dikemas kini 3 Jun 2026 · NCT03964506

A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).

  • Pfizer New York, New York
Mengambil pesertaKajian pemerhatian
Umur 20 ke atas · Semua jantina · Dikemas kini 14 Apr 2026 · NCT06297161

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Apr 2026 · NCT05304377

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 1
Umur 12 ke atas · Semua jantina · Dikemas kini 16 Mac 2026 · NCT06994676

A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)

  • Memorial Sloan Kettering Cancer Center - Main Campus, New York
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jan 2026 · NCT06163430

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

  • Roswell Park Comprehensive Cancer Center, Buffalo
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Nov 2025 · NCT03595917

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.